Merck (MRK) Net Income - Minority (2009 - 2012)

Merck (MRK) reported Net Income - Minority of -$2.4 billion for Q4 2012, down 0.7% year-over-year from -$2.5 billion in Q1 2012, and down 0.7% quarter-over-quarter from -$2.4 billion in Q4 2011.

Merck (MRK) Net Income - Minority (2009 - 2012) Analysis & Trends

Merck (MRK) has 4 years of Net Income - Minority data on file, last reported at -$2.4 billion in Q4 2012.

  • Net Income - Minority for Q4 2012 came in at -$2.4 billion, down 0.7% year-over-year; the trailing twelve-month figure through Dec 2012 was -$2.4 billion (down 0.7% YoY), and the FY2012 annual result was -$2.4 billion, down 0.7% from the prior year.
  • Net Income - Minority eased to -$2.4 billion in Q4 2012 per MRK's latest filing, from -$2.4 billion in the prior quarter.
  • Over five years, Net Income - Minority peaked at -$2.4 billion in Q4 2011 and troughed at -$2.5 billion in Q1 2010.
  • A 4-year average of -$2.4 billion and a median of -$2.4 billion in 2010 frame the typical range for Net Income - Minority.
  • The sharpest annual moves came in 2011 and 2012: Net Income - Minority advanced 0.41% in 2011, then retreated 0.7% in 2012.
  • A 4-year view of Net Income - Minority shows it stood at -$2.4 billion in 2009, then dropped by 0.08% to -$2.4 billion in 2010, then gained by 0.12% to -$2.4 billion in 2011, then declined by 0.7% to -$2.4 billion in 2012.
  • Business Quant data shows MRK's Net Income - Minority at -$2.4 billion in Q4 2012, -$2.4 billion in Q4 2011, and -$2.5 billion in Q1 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income - Minority (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn -
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn -
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn -
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn -
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn -
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn -
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2012 -2.44 Bn
Dec 31, 2011 -2.43 Bn
Mar 31, 2011 -2.46 Bn
Dec 31, 2010 -2.43 Bn
Sep 30, 2010 -2.46 Bn
Jun 30, 2010 -2.43 Bn
Mar 31, 2010 -2.47 Bn
Dec 31, 2009 -2.43 Bn